Abstracts (HTML) Autorenliste

---

• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• R
• S
• T
• V
• W
• Y
• Z
• Ö

Faignart, N.

Twenty-Year Trends in Time-to-Diagnosis of Paediatric Ischaemic Stroke in Switzerland

Fanto, M.

Epg5 Links Proteotoxic Stress Due to Defective Autophagic Clearance and Epileptogenesis in Drosophila and Vici Syndrome Patients

Feichtinger, R.

Genotypes and Phenotypes of a Novel Neurodevelopmental Disorder Caused by Biallelic Mutations in BUB1

Finanger, E. L.

Long-Term Safety of Givinostat in Patients with Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study

Finter, J.

EEG Changes Prior to Onset of Epilepsy: A Potential Early Biomarker to Monitor Disease Progression in CLN3 Disease

Flanigan, K.

Del-Zota Produced Statistically Significant Increases in Exon Skipping and Dystrophin Levels in EXPLORE44: A Phase 1/2 Study in Patients with DMD44

Floess, S.

Milde Arthrogryposis und Neonatal Beginnende Tonische Anfälle, Klinischer Verlauf, und Therapieansprechen bei SCN1A-c.2345C>T-Mutation als Hinweis auf eine GOF-Variante im Rahmen Eines NDEEMA-Spektrums

Fluss, J.

Twenty-Year Trends in Time-to-Diagnosis of Paediatric Ischaemic Stroke in Switzerland

Furgerson, M.

Long-Term Functional Outcomes, Safety, and Micro-Dystrophin Expression Following Delandistrogene Moxeparvovec Treatment in DMD: EMBARK 2-Year Results

Furtwängler, R.

Efficacy and Feasibility of the Mio-Training: A Metacognitive Intervention to Strengthen Cognitive Development of Children and Adolescents. An Evaluation Study